Toward a Rational Design of Clinical Trials of Immunosuppressive Agents in Transplantation
- 1 December 1993
- journal article
- review article
- Published by Wiley in Immunological Reviews
- Vol. 136 (1) , 29-49
- https://doi.org/10.1111/j.1600-065x.1993.tb00653.x
Abstract
No abstract availableKeywords
This publication has 41 references indexed in Scilit:
- The Reliability of Cost-Utility Estimates in Cost-Per-QALY League TablesPharmacoEconomics, 1993
- ENISOPROST IN RENAL TRANSPLANTATION1Transplantation, 1992
- ANALYSIS OF THE INTERACTIONS OF IMMUNOSUPPRESSIVE DRUGS WITH CYCLOSPORINE IN INHIBITING DNA PROLIFERATIONTransplantation, 1990
- THE IMPACT OF STEADY-STATE CYCLOSPORINE CONCENTRATIONS ON RENAL ALLOGRAFT OUTCOME1,2Transplantation, 1990
- CyclosporineNew England Journal of Medicine, 1989
- SERUM CYCLOSPORINE KINETIC PROFILETransplantation, 1988
- Effect of Antiidiotypic Antibodies to HLA on Graft Survival in Renal-Allograft RecipientsNew England Journal of Medicine, 1987
- A Randomized Clinical Trial of Cyclosporine in Cadaveric Renal TransplantationNew England Journal of Medicine, 1986
- The Quality of Life of Patients with End-Stage Renal DiseaseNew England Journal of Medicine, 1985
- Cyclosporine: Five Years' Experience in Cadaveric Renal TransplantationNew England Journal of Medicine, 1984